HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door open to mRNA therapies for cancer and genetic conditions.

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments for cancers, cystic fibrosis, and rare diseases.

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of mRNA vaccines are "simply not true."